L1	B:C3657719
retrotransposon	I:C3657719
expression	O
in	O
circulating	O
tumor	I:C0027625
cells	I:C0027625
.	O

L1	O
retrotransposon	I:C3657719
expression	B:C1171362
in	O
circulating	O
tumor	I:C0027625
cells	I:C0027625
.	O

L1	O
retrotransposon	I:C3657719
expression	O
in	O
circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
.	O

Long	B:C0600472
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	O
-	I:C0600472
1	I:C0600472
or	O
L1	O
)	O
belongs	O
to	O
the	O
non-long	O
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	O
and	O
disease	O
progression	I:C0242656
.	O

Long	O
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	B:C0600472
-	I:C0600472
1	I:C0600472
or	O
L1	O
)	O
belongs	O
to	O
the	O
non-long	O
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	O
and	O
disease	O
progression	I:C0242656
.	O

Long	O
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	O
-	I:C0600472
1	I:C0600472
or	O
L1	B:C0600472
)	O
belongs	O
to	O
the	O
non-long	O
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	O
and	O
disease	O
progression	I:C0242656
.	O

Long	O
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	O
-	I:C0600472
1	I:C0600472
or	O
L1	O
)	O
belongs	O
to	O
the	O
non-long	B:C0600401
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	O
and	O
disease	O
progression	I:C0242656
.	O

Long	O
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	O
-	I:C0600472
1	I:C0600472
or	O
L1	O
)	O
belongs	O
to	O
the	O
non-long	O
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	B:C0596263
and	O
disease	O
progression	I:C0242656
.	O

Long	O
interspersed	I:C0600472
nuclear	I:C0600472
element	I:C0600472
1	I:C0600472
(	O
LINE	O
-	I:C0600472
1	I:C0600472
or	O
L1	O
)	O
belongs	O
to	O
the	O
non-long	O
terminal	I:C0600401
repeat	I:C0600401
(	I:C0600401
non	I:C0600401
-	I:C0600401
LTR	I:C0600401
)	I:C0600401
retrotransposon	I:C0600401
family	I:C0600401
,	O
which	O
has	O
been	O
implicated	O
in	O
carcinogenesis	O
and	O
disease	B:C0242656
progression	I:C0242656
.	O

Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
(	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
)	O
are	O
also	O
known	O
to	O
be	O
involved	O
in	O
cancer	O
progression	I:C1947901
.	O

Circulating	O
tumor	I:C0027625
cells	I:C0027625
(	O
Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
)	O
are	O
also	O
known	O
to	O
be	O
involved	O
in	O
cancer	O
progression	I:C1947901
.	O

Circulating	O
tumor	I:C0027625
cells	I:C0027625
(	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
)	O
are	O
also	O
known	O
to	O
be	O
involved	O
in	O
cancer	B:C1947901
progression	I:C1947901
.	O

The	O
present	O
study	O
aimed	O
to	O
compare	O
the	O
L1	B:C3657719
expression	O
between	O
circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancerous	O
samples	O
.	O

The	O
present	O
study	O
aimed	O
to	O
compare	O
the	O
L1	O
expression	B:C1171362
between	O
circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancerous	O
samples	O
.	O

The	O
present	O
study	O
aimed	O
to	O
compare	O
the	O
L1	O
expression	O
between	O
circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancerous	O
samples	O
.	O

The	O
present	O
study	O
aimed	O
to	O
compare	O
the	O
L1	O
expression	O
between	O
circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancerous	B:C1268443
samples	O
.	O

Blood	B:C0178913
samples	I:C0178913
were	O
collected	O
from	O
10	O
healthy	O
individuals	O
and	O
22	O
patients	O
with	O
different	O
types	O
of	O
cancer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
from	O
10	O
healthy	O
individuals	B:C0237401
and	O
22	O
patients	O
with	O
different	O
types	O
of	O
cancer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
from	O
10	O
healthy	O
individuals	O
and	O
22	O
patients	O
with	O
different	O
types	O
of	O
cancer	B:C0006826
.	O

The	O
whole	B:C0005773
blood	I:C0005773
cells	I:C0005773
were	O
isolated	O
using	O
enrichment	O
protocols	O
and	O
the	O
DNA	O
and	O
RNA	O
were	O
extracted	O
.	O

The	O
whole	O
blood	I:C0005773
cells	I:C0005773
were	O
isolated	O
using	O
enrichment	O
protocols	B:C1507394
and	O
the	O
DNA	O
and	O
RNA	O
were	O
extracted	O
.	O

The	O
whole	O
blood	I:C0005773
cells	I:C0005773
were	O
isolated	O
using	O
enrichment	O
protocols	O
and	O
the	O
DNA	B:C0012854
and	O
RNA	O
were	O
extracted	O
.	O

The	O
whole	O
blood	I:C0005773
cells	I:C0005773
were	O
isolated	O
using	O
enrichment	O
protocols	O
and	O
the	O
DNA	O
and	O
RNA	B:C0035668
were	O
extracted	O
.	O

RT	B:C1514628
-	I:C1514628
qPCR	I:C1514628
was	O
performed	O
for	O
L1	O
-	I:C1530039
ORF1	I:C1530039
(	O
open	O
reading	O
frame	O
1	O
)	O
and	O
L1	O
-	I:C1530040
ORF2	I:C1530040
,	O
using	O
18S	O
rRNA	I:C0017337
as	O
the	O
reference	O
gene	O
.	O

RT	O
-	I:C1514628
qPCR	I:C1514628
was	O
performed	O
for	O
L1	B:C1530039
-	I:C1530039
ORF1	I:C1530039
(	O
open	O
reading	O
frame	O
1	O
)	O
and	O
L1	O
-	I:C1530040
ORF2	I:C1530040
,	O
using	O
18S	O
rRNA	I:C0017337
as	O
the	O
reference	O
gene	O
.	O

RT	O
-	I:C1514628
qPCR	I:C1514628
was	O
performed	O
for	O
L1	O
-	I:C1530039
ORF1	I:C1530039
(	O
open	O
reading	O
frame	O
1	O
)	O
and	O
L1	B:C1530040
-	I:C1530040
ORF2	I:C1530040
,	O
using	O
18S	O
rRNA	I:C0017337
as	O
the	O
reference	O
gene	O
.	O

RT	O
-	I:C1514628
qPCR	I:C1514628
was	O
performed	O
for	O
L1	O
-	I:C1530039
ORF1	I:C1530039
(	O
open	O
reading	O
frame	O
1	O
)	O
and	O
L1	O
-	I:C1530040
ORF2	I:C1530040
,	O
using	O
18S	B:C0017337
rRNA	I:C0017337
as	O
the	O
reference	O
gene	O
.	O

RT	O
-	I:C1514628
qPCR	I:C1514628
was	O
performed	O
for	O
L1	O
-	I:C1530039
ORF1	I:C1530039
(	O
open	O
reading	O
frame	O
1	O
)	O
and	O
L1	O
-	I:C1530040
ORF2	I:C1530040
,	O
using	O
18S	O
rRNA	I:C0017337
as	O
the	O
reference	O
gene	B:C0017337
.	O

The	O
data	O
were	O
analyzed	O
with	O
the	O
Livak	B:C3900047
method	I:C3900047
and	O
statistical	O
analyses	O
were	O
carried	O
out	O
with	O
the	O
Mann	O
-	I:C1708930
Whitney	I:C1708930
and	O
Kruskal	O
-	I:C1708614
Wallis	I:C1708614
tests	I:C1708614
.	O

The	O
data	O
were	O
analyzed	O
with	O
the	O
Livak	O
method	I:C3900047
and	O
statistical	O
analyses	O
were	O
carried	O
out	O
with	O
the	O
Mann	B:C1708930
-	I:C1708930
Whitney	I:C1708930
and	O
Kruskal	O
-	I:C1708614
Wallis	I:C1708614
tests	I:C1708614
.	O

The	O
data	O
were	O
analyzed	O
with	O
the	O
Livak	O
method	I:C3900047
and	O
statistical	O
analyses	O
were	O
carried	O
out	O
with	O
the	O
Mann	O
-	I:C1708930
Whitney	I:C1708930
and	O
Kruskal	B:C1708614
-	I:C1708614
Wallis	I:C1708614
tests	I:C1708614
.	O

In	O
parallel	O
with	O
the	O
above	O
molecular	B:C0681814
biology	I:C0681814
experiments	I:C0681814
,	O
FISH	O
experiments	I:C0162789
were	O
performed	O
on	O
the	O
interphase	O
nuclei	I:C0230528
of	O
the	O
cells	O
for	O
the	O
detection	O
of	O
ORF2	O
RNA	O
.	O

In	O
parallel	O
with	O
the	O
above	O
molecular	O
biology	I:C0681814
experiments	I:C0681814
,	O
FISH	B:C0162789
experiments	I:C0162789
were	O
performed	O
on	O
the	O
interphase	O
nuclei	I:C0230528
of	O
the	O
cells	O
for	O
the	O
detection	O
of	O
ORF2	O
RNA	O
.	O

In	O
parallel	O
with	O
the	O
above	O
molecular	O
biology	I:C0681814
experiments	I:C0681814
,	O
FISH	O
experiments	I:C0162789
were	O
performed	O
on	O
the	O
interphase	B:C0230528
nuclei	I:C0230528
of	O
the	O
cells	O
for	O
the	O
detection	O
of	O
ORF2	O
RNA	O
.	O

In	O
parallel	O
with	O
the	O
above	O
molecular	O
biology	I:C0681814
experiments	I:C0681814
,	O
FISH	O
experiments	I:C0162789
were	O
performed	O
on	O
the	O
interphase	O
nuclei	I:C0230528
of	O
the	O
cells	B:C0007634
for	O
the	O
detection	O
of	O
ORF2	O
RNA	O
.	O

In	O
parallel	O
with	O
the	O
above	O
molecular	O
biology	I:C0681814
experiments	I:C0681814
,	O
FISH	O
experiments	I:C0162789
were	O
performed	O
on	O
the	O
interphase	O
nuclei	I:C0230528
of	O
the	O
cells	O
for	O
the	O
detection	B:C0442726
of	O
ORF2	O
RNA	O
.	O

DNA	B:C0200898
analysis	I:C0200898
revealed	O
the	O
presence	O
of	O
both	O
ORF1	O
and	O
ORF2	O
in	O
all	O
samples	O
.	O

DNA	O
analysis	I:C0200898
revealed	O
the	O
presence	B:C0150312
of	O
both	O
ORF1	O
and	O
ORF2	O
in	O
all	O
samples	O
.	O

DNA	O
analysis	I:C0200898
revealed	O
the	O
presence	O
of	O
both	O
ORF1	B:C2604410
and	O
ORF2	O
in	O
all	O
samples	O
.	O

DNA	O
analysis	I:C0200898
revealed	O
the	O
presence	O
of	O
both	O
ORF1	O
and	O
ORF2	B:C2604420
in	O
all	O
samples	O
.	O

RNA	B:C1171362
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	B:C0681814
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	B:C2604410
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	B:C1171362
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	B:C2604420
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	B:C1171362
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	B:C1268443
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	O
types	O
.	O

RNA	O
expression	I:C1171362
experiments	O
demonstrated	O
that	O
ORF1	O
was	O
not	O
expressed	O
in	O
all	O
samples	O
,	O
while	O
ORF2	O
was	O
expressed	O
at	O
varying	O
levels	O
in	O
the	O
non-cancer	O
samples	O
and	O
the	O
samples	O
representing	O
the	O
different	O
cancer	B:C0006826
types	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	B:C2604420
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	B:C1171362
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	B:C1268443
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	B:C1268443
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	B:C0334227
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	B:C0334227
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	B:C0334227
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	B:C0334227
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	O
samples	O
.	O

A	O
significant	O
difference	O
in	O
ORF2	O
expression	O
was	O
observed	O
between	O
the	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
non-cancer	O
samples	O
(	O
p	O
=	O
0,00043	O
)	O
,	O
and	O
significant	O
differences	O
were	O
also	O
observed	O
between	O
normal	O
and	O
lung	O
(	O
p	O
=	O
0,034	O
)	O
,	O
pancreatic	O
(	O
p	O
=	O
0,022	O
)	O
,	O
prostate	O
(	O
p	O
=	O
0,014	O
)	O
,	O
and	O
unknown	O
primary	I:C0334227
of	I:C0334227
origin	I:C0334227
(	O
p	O
=	O
0,0039	O
)	O
cancer	B:C0006826
samples	O
.	O

Cytogenetic	B:C0752095
analysis	I:C0752095
revealed	O
higher	O
levels	O
of	O
ORF2	O
in	O
the	O
nuclei	O
of	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
than	O
in	O
normal	O
samples	I:C1268443
.	O

Cytogenetic	O
analysis	I:C0752095
revealed	O
higher	O
levels	O
of	O
ORF2	B:C2604420
in	O
the	O
nuclei	O
of	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
than	O
in	O
normal	O
samples	I:C1268443
.	O

Cytogenetic	O
analysis	I:C0752095
revealed	O
higher	O
levels	O
of	O
ORF2	O
in	O
the	O
nuclei	B:C0007610
of	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
than	O
in	O
normal	O
samples	I:C1268443
.	O

Cytogenetic	O
analysis	I:C0752095
revealed	O
higher	O
levels	O
of	O
ORF2	O
in	O
the	O
nuclei	O
of	O
Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
than	O
in	O
normal	O
samples	I:C1268443
.	O

Cytogenetic	O
analysis	I:C0752095
revealed	O
higher	O
levels	O
of	O
ORF2	O
in	O
the	O
nuclei	O
of	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
than	O
in	O
normal	B:C1268443
samples	I:C1268443
.	O

This	O
study	O
highlights	O
the	O
significant	O
difference	O
in	O
L1	B:C1530040
-	I:C1530040
ORF2	I:C1530040
expression	O
between	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
normal	O
samples	I:C1268443
.	O

This	O
study	O
highlights	O
the	O
significant	O
difference	O
in	O
L1	O
-	I:C1530040
ORF2	I:C1530040
expression	B:C1171362
between	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
normal	O
samples	I:C1268443
.	O

This	O
study	O
highlights	O
the	O
significant	O
difference	O
in	O
L1	O
-	I:C1530040
ORF2	I:C1530040
expression	O
between	O
Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
and	O
normal	O
samples	I:C1268443
.	O

This	O
study	O
highlights	O
the	O
significant	O
difference	O
in	O
L1	O
-	I:C1530040
ORF2	I:C1530040
expression	O
between	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
and	O
normal	B:C1268443
samples	I:C1268443
.	O

The	O
increased	O
expression	O
levels	O
observed	O
for	O
Circulating	B:C0027625
tumor	I:C0027625
cells	I:C0027625
may	O
be	O
correlated	O
with	O
the	O
characteristic	O
features	O
of	O
these	O
cells	O
.	O

The	O
increased	O
expression	O
levels	O
observed	O
for	O
Circulating	O
tumor	I:C0027625
cells	I:C0027625
may	O
be	O
correlated	O
with	O
the	O
characteristic	O
features	O
of	O
these	O
cells	B:C0007634
.	O

